ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.

Caitlyn L Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.